Storage and handling
Other information Store at room temperature Lot number and expiration date are printed on back panel.
Other information Store at room temperature Lot number and expiration date are printed on back panel.
Drug Facts
Active ingredient
Pyrithione zinc 2%
Purpose
Dandruff, Seborrheic dermatitis
Uses
Controls and reduces the symptoms of dandruff and seborrheic dermatitis.
Warnings
For external use only
Ask a doctor before use if you havea condition that covers a large area of the body.
When using this productavoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and ask a doctor ifcondition worsens or does not improve after regular use as directed.
Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Other information
Inactive ingredients
Sodium palmate, sodium cocoate*, sodium palm kernelate*, water, glycerin, titanium dioxide, Avena Sativa (oat) kernel flour, olive oil, vitamin E, table salt, pentasodium pentetate
Distributed by:
D3 Development, Inc., Portland, ME 04101
Made in the USA
dermaharmony
Zinc Therapy SOAP
2% Pyrithione Zinc for Seborrheic Dermatitis & Dandruff
NET WT 4.0 OZ (113 G)
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71819-001-01 | Zinc Therapy | 28 g in 1 CELLO PACK | SOAP | 28 | 4 | |
| 71819-001-04 | Zinc Therapy | 113 g in 1 CELLO PACK | SOAP | 113 | 4 | |
| 71819-001-05 | Zinc Therapy | 113 g in 1 CARTON | SOAP | 113 | 4 | |
| 71819-001-44 | Zinc Therapy | 226 g in 1 CELLO PACK | SOAP | 226 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71819-001 | 71819-001-01, 71819-001-04, 71819-001-44, 71819-001-05 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM COCOATE | R1TQH25F4I | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| OATMEAL | 8PI54V663Y | IACT |
| SODIUM PALM KERNELATE | 6H91L1NXTW | IACT |
| OLIVE OIL | 6UYK2W1W1E | IACT |
| SODIUM PALMATE | S0A6004K3Z | IACT |
| .ALPHA.-TOCOPHEROL ACETATE, D- | A7E6112E4N | IACT |
| PENTASODIUM PENTETATE | 961TOZ5L7T | IACT |
| PYRITHIONE ZINC | R953O2RHZ5 | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 2 | 2020-03-24 | full-release | 2026-05-31 23:04:07 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zinc Therapy | PYRITHIONE ZINC | D3 Development, Inc. | 6b2de5ba-ad4b-5d43-e053-2991aa0ac3b2 | 2025-12-02 | Warnings | 71819-001-05 71819-001-01 71819-001-04 71819-001-44 71819-001 71819000144 71819000104 71819000101 71819000105 44fdf832-7277-4c93-e063-6294a90a61e1 6b2de5ba-ad4b-5d43-e053-2991aa0ac3b2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.